KDR Gene Hemangioma Capillary Infantile Familial Susceptibility to Genetic Test sale cost 4400 AED
PIK3CA Gene Cowden Syndrome Type 5 Genetic Test sale cost 4400 AED PIK3CA Gene Cowden Syndrome Type 5 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
TP53 Gene Li-Fraumeni Syndrome Type 1 Genetic Test sale cost 4400 AED TP53 Gene Li-Fraumeni Syndrome Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KDR Gene Hemangioma Capillary Infantile Familial Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KDR Gene Hemangioma Capillary Infantile Familial Susceptibility genetic test is a specialized diagnostic tool aimed at identifying genetic predispositions to Infantile Capillary Hemangiomas within families. These benign vascular tumors, most commonly seen in infants, are characterized by their rapid growth phase followed by a slower involution phase. The KDR gene plays a crucial role in the development of these hemangiomas, as mutations in this gene are associated with an increased risk of developing the condition.

This genetic test, conducted at DNA Labs UAE, is a significant advancement in the early detection and management of capillary hemangiomas. By analyzing specific markers in the KDR gene, the test can identify individuals who carry genetic mutations that predispose them to this condition, facilitating early intervention and monitoring for affected infants and their families.

The test is priced at 4400 AED, reflecting the specialized nature of the analysis and the invaluable insights it provides for affected families. By opting for this test, parents and healthcare providers can take proactive steps towards managing and treating infantile capillary hemangiomas, potentially minimizing complications and improving the quality of life for those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KDR Gene Hemangioma Capillary Infantile Familial Susceptibility to Genetic Test

Test Name: KDR Gene Hemangioma Capillary Infantile Familial Susceptibility to Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic DNA Test gene KDR

Test Details

The KDR gene, also known as the kinase insert domain receptor gene, is associated with a condition called infantile hemangioma. Hemangiomas are benign tumors that develop in infancy, typically appearing as a red, raised birthmark on the skin. The capillary infantile hemangioma is a specific type of hemangioma that affects the capillaries.

Familial infantile hemangioma refers to cases where there is a genetic predisposition for the development of hemangiomas within a family. In these cases, there may be a higher likelihood of multiple family members being affected by the condition.

Susceptibility to NGS genetic testing refers to the potential for using Next-Generation Sequencing (NGS) technology to identify genetic variations or mutations that may contribute to the development of infantile hemangioma. NGS allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of an individual’s genetic makeup.

Therefore, the “KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic Test” refers to a genetic test that aims to identify genetic variations in the KDR gene and other relevant genes associated with capillary infantile hemangioma, particularly in families with a history of the condition. This test can help in understanding the genetic basis of the disease and potentially aid in diagnosis, prognosis, and personalized treatment options.

Test Name KDR Gene Hemangioma capillary infantile familial susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic DNA Test gene KDR
Test Details

The KDR gene, also known as the kinase insert domain receptor gene, is associated with a condition called infantile hemangioma. Hemangiomas are benign tumors that develop in infancy, typically appearing as a red, raised birthmark on the skin. The capillary infantile hemangioma is a specific type of hemangioma that affects the capillaries.

Familial infantile hemangioma refers to cases where there is a genetic predisposition for the development of hemangiomas within a family. In these cases, there may be a higher likelihood of multiple family members being affected by the condition.

Susceptibility to NGS genetic testing refers to the potential for using Next-Generation Sequencing (NGS) technology to identify genetic variations or mutations that may contribute to the development of infantile hemangioma. NGS allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of an individual’s genetic makeup.

Therefore, the “KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic Test” refers to a genetic test that aims to identify genetic variations in the KDR gene and other relevant genes associated with capillary infantile hemangioma, particularly in families with a history of the condition. This test can help in understanding the genetic basis of the disease and potentially aid in diagnosis, prognosis, and personalized treatment options.

SKU: TEST-4493 Category:

Related products